American College of Cardiology

GREGORATOS ET AL., ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices
http://www.acc.org/clinical/guidelines/pacemaker/incorporated/index.htm; 2002

ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Full Text

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Implantation)

Committee Members
Gabriel Gregoratos, MD, FACC, FAHA, Chair; Jonathan Abrams, MD, FACC, FAHA; Andrew E. Epstein, MD, FACC, FAHA; Roger A. Freedman, MD, FACC; David L. Hayes, MD, FACC, FAHA; Mark A. Hlatky, MD, FACC, FAHA; Richard E. Kerber, MD, FACC, FAHA; Gerald V. Naccarelli, MD, FACC, FAHA; Mark H. Schoenfeld, MD, FACC, FAHA; Michael J. Silka, MD, FACC; Stephen L. Winters, MD, FACC

Task Force Members
Raymond J. Gibbons, MD, FACC, FAHA, Chair; Elliott M. Antman, MD, FACC, FAHA, Vice Chair; Joseph S. Alpert, MD, FACC, FAHA; David P. Faxon, MD, FACC, FAHA; Valentin Fuster, MD, PhD, FACC, FAHA; Gabriel Gregoratos, MD, FACC, FAHA; Loren F. Hiratzka, MD, FACC, FAHA; Alice K. Jacobs, MD, FACC, FAHA; Sidney C. Smith, Jr., MD, FACC, FAHA

Table of Contents:

Preamble

Introduction

1. Indications for Permanent Pacing
   1. Pacing for Acquired Atrioventricular Block in Adults
   2. Pacing for Chronic Bifascicular and Trifascicular Block
   3. Pacing for Atrioventricular Block Associated With Acute Myocardial Infarction
   4. Pacing in Sinus Node Dysfunction
   5. Prevention and Termination of Tachyarrhythmias by Pacing
   6. Pacing in Hypersensitive Carotid Sinus and Neurocardiogenic Syncope
   7. Pacing in Children, Adolescents, and Patients With Congenital Heart Disease
   8. Pacing in Specific Conditions
      1. Hypertrophic Obstructive Cardiomyopathy
      2. Idiopathic Dilated Cardiomyopathy
      3. Cardiac Transplantation
   9. Selection of Pacemaker Device
      1. Newer Technical Innovations
      2. Methodology of Comparing Different Pacing Modes
      3. Pacing in Sinus Node Dysfunction
      4. Pacing in Atrioventricular Block
      5. Pacing in the Elderly
      6. Optimizing Pacemaker Technology and Cost
   10. Pacemaker Follow-up
       1. Amount of Time Necessary for Verification
       2. Length of Electrocardiographic Samples for Storage
       3. Frequency of Transtelephonic Monitorin
2. Indications for Implantable Cardioverter-Defibrillator Therapy
   1. Background
   2. Clinical Efficiency of ICD Therapy
   3. Alternatives to ICD Therapy
   4. Comparison of Drug and Device Therapy for Secondary Prevention of Cardiac Arrest and Sustained Ventricular Tachycardia
   5. Specific Disease States and Secondary Prevention of Cardiac Arrest or Sustained VentricularTachycardia
      1. Coronary Artery Disease
      2. Idiopathic Dilated Cardiomyopathy
      3. Long-QT Syndrome
      4. Idiopathic Ventricular Fibrillation
      5. Idiopathic Ventricular Tachycardia
      6. Hypertrophic Cardiomyopathy
      7. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
      8. Syncope With Inducible Sustained Ventricular Tachycardia
   6. Pediatric Patients
   7. Primary Prevention of Sudden Cardiac Death
      1. Coronary Artery Disease
      2. After Coronary Artery Bypass Surgery
      3. As a Bridge to Heart Transplantation
      4. Other Populations
   8. Contraindications and Limitations of ICD Therapy
   9. Cost-Effectiveness of ICD Therapy
   10. Selection of ICD Generators
   11. ICD Follow-up
       1. Elements of ICD Follow-up
          

Appendix

Staff and Acknowledgement

Tables and Figures

References

This document is available on the World Wide Web sites of the ACC (www.acc.org), the AHA (www.americanheart.org), and the NASPE (www.naspe.org). Copies of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699 (ask for No. 71-0237). To obtain a reprint of the shorter version (summary article describing the changes to the guidelines) planned for subsequent publication in J Am Coll Cardiol and Circulation, ask for reprint No. 71-0236. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665- 2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org.

© 2002 by the American College of Cardiology Foundation and the American Heart Association, Inc.